Related Experiment Video
Updated: Jul 6, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
MUC1 and colorectal cancer pathophysiology considerations
1Department of Gastroenterology, Rabin Medical Center, Petach Tikva 49100, Israel. yniv@clalit.org.il
World Journal of Gastroenterology
|April 15, 2008
Summary
Mucin 1 (MUC1) plays a complex role in colorectal cancer (CRC), potentially inhibiting proliferation via beta-catenin. Its altered expression disrupts cell adhesion and promotes gene expression, impacting CRC progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Mucin 1 (MUC1) is implicated in colorectal cancer (CRC) progression, with observed correlations to increased secretion, proliferation, invasiveness, metastasis, and poor prognosis.
- The precise role of MUC1 in cancer progression remains debated, with conflicting findings regarding its influence on cell proliferation.
Purpose of the Study:
- To elucidate the controversial role of MUC1 in colorectal cancer progression.
- To investigate the molecular mechanisms by which MUC1 influences cancer cell behavior.
Main Methods:
- Analysis of MUC1 expression and localization in carcinoma cells.
- Investigation of MUC1 interactions with E-cadherin and beta-catenin.
- Assessment of MUC1-beta-catenin complex translocation to the nucleus and its effect on gene expression.
Main Results:
- MUC1 is overexpressed and loses normal polarization in carcinoma cells.
- MUC1 competitively interacts with E-cadherin via beta-catenin, disrupting cell-cell adhesion.
- The MUC1-beta-catenin complex translocates to the nucleus, activating transcription factors and promoting gene expression, potentially influencing proliferation and migration.
Conclusions:
- MUC1's altered expression and localization in CRC contribute to disrupted cell adhesion and altered gene expression.
- MUC1, through its interaction with beta-catenin, may promote CRC progression by influencing cell proliferation, differentiation, and migration.
- Further research is needed to fully understand MUC1's multifaceted role in colorectal cancer.
Related Concept Videos
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:28Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:25Mucosal Barrier of the Stomach
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...